BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang R, Chen Z, He L, He N, Xi Z, Li Z, Deng Y, Zeng X. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application. Theranostics 2017;7:3559-72. [PMID: 28912895 DOI: 10.7150/thno.20797] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Wang K, Luo L. AuNPs and 2D functional nanomaterial-assisted SPR development for the cancer detection: a critical review. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00138-7] [Reference Citation Analysis]
2 Shansky Y, Bespyatykh J. Bile Acids: Physiological Activity and Perspectives of Using in Clinical and Laboratory Diagnostics. Molecules 2022;27:7830. [DOI: 10.3390/molecules27227830] [Reference Citation Analysis]
3 Guo Y, Li Q, Ren W, Wu H, Wang C, Li X, Xue B, Qiu Y, Zhang J, Chen J, Fang L. Quantitative Proteomics Reveals Down-Regulated Glycolysis/Gluconeogenesis in the Large-Duct Type Intrahepatic Cholangiocarcinoma. J Proteome Res 2022. [PMID: 36066509 DOI: 10.1021/acs.jproteome.2c00472] [Reference Citation Analysis]
4 Li Z, Ke Y. DNA Nanostructures for Cancer Diagnosis and Therapy. DNA Origami 2022. [DOI: 10.1002/9781119682561.ch17] [Reference Citation Analysis]
5 Luo H, Ge H. Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers. Front Oncol 2022;12:852791. [PMID: 35280744 DOI: 10.3389/fonc.2022.852791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wu Y, Chen H, Chen Y, Sun N, Deng C. Metal organic frameworks as advanced extraction adsorbents for separation and analysis in proteomics and environmental research. Sci China Chem . [DOI: 10.1007/s11426-021-1195-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wei S, Liu W, Xu M, Qin H, Liu C, Zhang R, Zhou S, Li E, Liu Z, Wang Q. Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer. Br J Cancer 2022. [PMID: 35217799 DOI: 10.1038/s41416-022-01744-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Guo Z, Jin B, Fang Y, Deng Y, Chen Z, Chen H, Li S, Leung P, Wang H, Cai L, He N. Selected aptamer specially combing 5-8F cells based on automatic screening instrument. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Iftikhar M, Younis A, Lee YS, Shehzad A. Introduction to Cancer Biomarkers. Cancer Biomarkers in Diagnosis and Therapeutics 2022. [DOI: 10.1007/978-981-16-5759-7_1] [Reference Citation Analysis]
10 Sen R, Thathapudi NC, Sharma D, Shome I, Singh SP, Magisetty O, Jangamreddy JR. Tumor Models of Retinoblastoma: In Vivo, Ex Vivo, and In Vitro Models. Handbook of Animal Models and its Uses in Cancer Research 2022. [DOI: 10.1007/978-981-19-1282-5_30-1] [Reference Citation Analysis]
11 Niu C, Lin X, Jiang X, Guo F, Liu J, Liu X, Huang H, Huang Y. An electrochemical aptasensor for highly sensitive detection of CEA based on exonuclease III and hybrid chain reaction dual signal amplification. Bioelectrochemistry 2022;143:107986. [PMID: 34735912 DOI: 10.1016/j.bioelechem.2021.107986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Zhong Y, Zhuang Z, Mo P, Shang Q, Lin M, Gong J, Huang J, Mo H, Huang M. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer. Evid Based Complement Alternat Med 2021;2021:5557873. [PMID: 34567213 DOI: 10.1155/2021/5557873] [Reference Citation Analysis]
13 Erozenci LA, Piersma SR, Pham TV, Bijnsdorp IV, Jimenez CR. Longitudinal stability of urinary extracellular vesicle protein patterns within and between individuals. Sci Rep 2021;11:15629. [PMID: 34341426 DOI: 10.1038/s41598-021-95082-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Bickner AN, Champion MM, Hummon AB, Bruening ML. Electroblotting through a tryptic membrane for LC-MS/MS analysis of proteins separated in electrophoretic gels. Analyst 2020;145:7724-35. [PMID: 33000802 DOI: 10.1039/d0an01380c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bian J, Sze YH, Tse DY, To CH, McFadden SA, Lam CS, Li KK, Lam TC. SWATH Based Quantitative Proteomics Reveals Significant Lipid Metabolism in Early Myopic Guinea Pig Retina. Int J Mol Sci 2021;22:4721. [PMID: 33946922 DOI: 10.3390/ijms22094721] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
16 Chen CJ, Chou CY, Shu KH, Chen HC, Wang MC, Chang CC, Hsu BG, Wu MS, Yang YL, Liao WL, Yang C, Hsiao YT, Huang CC. Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics. J Proteome Res 2021;20:2953-63. [PMID: 33780252 DOI: 10.1021/acs.jproteome.1c00164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Orfanou IM, Argyros O, Papapetropoulos A, Tseleni-Balafouta S, Vougas K, Tamvakopoulos C. Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer. Front Oncol 2021;11:608201. [PMID: 33842315 DOI: 10.3389/fonc.2021.608201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Yue X, Chen L, Wang C, Cao X, Guo M. Human milk proteomics and lipidomics and human milk microbiome. Human Milk Biochemistry and Infant Formula Manufacturing Technology 2021. [DOI: 10.1016/b978-0-08-102898-8.00004-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sun Q, Han Y, Yang Y, de la Fuente JM, Cui D, Wang X. Application of DNA nanostructures in cancer therapy. Applied Materials Today 2020;21:100861. [DOI: 10.1016/j.apmt.2020.100861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Sarbu M, Clemmer DE, Zamfir AD. Ion mobility mass spectrometry of human melanoma gangliosides. Biochimie 2020;177:226-37. [DOI: 10.1016/j.biochi.2020.08.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Bhawal R, Oberg AL, Zhang S, Kohli M. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer. Cancers (Basel) 2020;12:E2428. [PMID: 32867043 DOI: 10.3390/cancers12092428] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
22 Bai Y, Zhang H, Zhao L, Wang Y, Chen X, Zhai H, Tian M, Zhao R, Wang T, Xu H, Feng F. A novel aptasensor based on HCR and G-quadruplex DNAzyme for fluorescence detection of Carcinoembryonic Antigen. Talanta 2021;221:121451. [PMID: 33076074 DOI: 10.1016/j.talanta.2020.121451] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
23 Sun J, Sun X. Recent advances in the construction of DNA nanostructure with signal amplification and ratiometric response for miRNA sensing and imaging. TrAC Trends in Analytical Chemistry 2020;127:115900. [DOI: 10.1016/j.trac.2020.115900] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
24 Shu W, Wang Y, Liu C, Li R, Pei C, Lou W, Lin S, Di W, Wan J. Construction of a Plasmonic Chip for Metabolic Analysis in Cervical Cancer Screening and Evaluation. Small Methods 2020;4:1900469. [DOI: 10.1002/smtd.201900469] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 22.5] [Reference Citation Analysis]
25 Xiao M, Lai W, Man T, Chang B, Li L, Chandrasekaran AR, Pei H. Rationally Engineered Nucleic Acid Architectures for Biosensing Applications. Chem Rev 2019;119:11631-717. [DOI: 10.1021/acs.chemrev.9b00121] [Cited by in Crossref: 146] [Cited by in F6Publishing: 147] [Article Influence: 48.7] [Reference Citation Analysis]
26 Jasim H, Carlsson A, Gerdle B, Ernberg M, Ghafouri B. Diurnal variation of inflammatory plasma proteins involved in pain. Pain Rep 2019;4:e776. [PMID: 31875183 DOI: 10.1097/PR9.0000000000000776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
27 Erozenci LA, Böttger F, Bijnsdorp IV, Jimenez CR. Urinary exosomal proteins as (pan‐)cancer biomarkers: insights from the proteome. FEBS Lett 2019;593:1580-97. [DOI: 10.1002/1873-3468.13487] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
28 Salerno C, Berardi G, Laera G, Pollice A. Functional Response of MBR Microbial Consortia to Substrate Stress as Revealed by Metaproteomics. Microb Ecol 2019;78:873-84. [DOI: 10.1007/s00248-019-01360-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
29 Umaña-pérez YA, Calderón Rodriguez SI. Estudio proteómico 2DE-DIGE en plasma sanguíneo de pacientes en etapa infantil con leucemia linfoblástica aguda. Rev colomb quim 2019;48:5-15. [DOI: 10.15446/rev.colomb.quim.v48n1.75170] [Reference Citation Analysis]
30 Lin H, He QY, Shi L, Sleeman M, Baker MS, Nice EC. Proteomics and the microbiome: pitfalls and potential. Expert Rev Proteomics 2019;16:501-11. [PMID: 30223687 DOI: 10.1080/14789450.2018.1523724] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
31 Gu Z, Li Y, Yang X, Yu M, Chen Z, Zhao C, Chen L, Wang L. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer. J Hematol Oncol 2018;11:115. [PMID: 30217218 DOI: 10.1186/s13045-018-0660-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
32 Latosinska A, Frantzi M, Merseburger AS, Mischak H. Promise and Implementation of Proteomic Prostate Cancer Biomarkers. Diagnostics (Basel) 2018;8:E57. [PMID: 30158500 DOI: 10.3390/diagnostics8030057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
33 Qu X, Xiao M, Li F, Lai W, Li L, Zhou Y, Lin C, Li Q, Ge Z, Wen Y, Pei H, Liu G. Framework Nucleic Acid-Mediated Pull-Down MicroRNA Detection with Hybridization Chain Reaction Amplification. ACS Appl Bio Mater 2018;1:859-64. [DOI: 10.1021/acsabm.8b00278] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
34 Schroll MM, Hummon AB. Employing proteomics to understand the effects of nutritional intervention in cancer treatment. Anal Bioanal Chem 2018;410:6371-86. [PMID: 29974151 DOI: 10.1007/s00216-018-1219-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
35 Huang R, He N, Li Z. Recent progresses in DNA nanostructure-based biosensors for detection of tumor markers. Biosensors and Bioelectronics 2018;109:27-34. [DOI: 10.1016/j.bios.2018.02.053] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 27.0] [Reference Citation Analysis]
36 Cintas C, Douché T, Therville N, Arcucci S, Ramos-Delgado F, Basset C, Thibault B, Guillermet-Guibert J. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Cancers (Basel) 2018;10:E174. [PMID: 29865155 DOI: 10.3390/cancers10060174] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]